Tvardi Therapeutics, Inc. Common Stock (TVRD) is a publicly traded Healthcare sector company. As of August 26, 2026, TVRD trades at $1.81 with a market cap of $23.74M and a P/E ratio of -0.74. TVRD moved +0.00% today. Year to date, TVRD is -55.39%; over the trailing twelve months it is -93.77%. Its 52-week range spans $1.50 to $43.65. Analyst consensus is buy with an average price target of $8.67. Rallies surfaces TVRD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for TVRD shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $1.81 |
| Market Cap | $23.74M |
| P/E Ratio | -0.74 |
| EPS | $-2.46 |
| Dividend Yield | 0.00% |
| 52-Week High | $43.65 |
| 52-Week Low | $1.50 |
| Volume | 4.97K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-18.21M |
| Gross Margin | 0.00% |
7 analysts cover TVRD: 0 strong buy, 5 buy, 1 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $8.67.